Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk

Clinical trial NCT04570956 · TERMINATED

Trial details

NCT number: NCT04570956
Sponsor: Mayo Clinic
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Atypical Hyperplasia Breast Lobular Carcinoma in Situ Breast Atypical Lobular Hyperplasia Breast Carcinoma

Start date: 2021-07-26
Primary completion: 2024-10-15
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.